These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The complex contribution of chemokines to neuroinflammation: switching from beneficial to detrimental effects. Le Thuc O; Blondeau N; Nahon JL; Rovère C Ann N Y Acad Sci; 2015 Sep; 1351():127-40. PubMed ID: 26251227 [TBL] [Abstract][Full Text] [Related]
7. [Inflammation and Alzheimer's disease]. de Toledo M Rev Neurol; 2006 Apr 1-15; 42(7):433-8. PubMed ID: 16602061 [TBL] [Abstract][Full Text] [Related]
8. Inflammation of the brain in Alzheimer's disease: implications for therapy. McGeer PL; McGeer EG J Leukoc Biol; 1999 Apr; 65(4):409-15. PubMed ID: 10204568 [TBL] [Abstract][Full Text] [Related]
10. Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Aisen PS; Davis KL Am J Psychiatry; 1994 Aug; 151(8):1105-13. PubMed ID: 7518651 [TBL] [Abstract][Full Text] [Related]
11. Inflammation and Alzheimer's disease. Lee YJ; Han SB; Nam SY; Oh KW; Hong JT Arch Pharm Res; 2010 Oct; 33(10):1539-56. PubMed ID: 21052932 [TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease, inflammation and non-steroidal anti-inflammatory drugs. Ferencik M; Novak M; Rovensky J; Rybar I Bratisl Lek Listy; 2001; 102(3):123-32. PubMed ID: 11433600 [TBL] [Abstract][Full Text] [Related]
13. Neuroimmunomodulation in the pathogenesis of Alzheimer's disease. Morales I; Farías G; Maccioni RB Neuroimmunomodulation; 2010; 17(3):202-4. PubMed ID: 20134203 [TBL] [Abstract][Full Text] [Related]
14. Neuroinflammation in Alzheimer's disease and prion disease. Eikelenboom P; Bate C; Van Gool WA; Hoozemans JJM; Rozemuller JM; Veerhuis R; Williams A Glia; 2002 Nov; 40(2):232-239. PubMed ID: 12379910 [TBL] [Abstract][Full Text] [Related]
15. Innate immunity in Alzheimer's disease: a model for local inflammatory reactions. McGeer EG; McGeer PL Mol Interv; 2001 Apr; 1(1):22-9. PubMed ID: 14993335 [TBL] [Abstract][Full Text] [Related]
17. Assessing activation states in microglia. Colton C; Wilcock DM CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):174-91. PubMed ID: 20205642 [TBL] [Abstract][Full Text] [Related]
18. Pentraxins and Alzheimer's disease: at the interface between biomarkers and pharmacological targets. Osera C; Pascale A; Amadio M; Venturini L; Govoni S; Ricevuti G Ageing Res Rev; 2012 Apr; 11(2):189-98. PubMed ID: 22186030 [TBL] [Abstract][Full Text] [Related]
19. Understanding the Role of Systemic Inflammation in Alzheimer's Disease. Walker KA; Ficek BN; Westbrook R ACS Chem Neurosci; 2019 Aug; 10(8):3340-3342. PubMed ID: 31241312 [TBL] [Abstract][Full Text] [Related]
20. Neuroinflammation in Alzheimer's disease: protector or promoter? Zilka N; Ferencik M; Hulin I Bratisl Lek Listy; 2006; 107(9-10):374-83. PubMed ID: 17262990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]